Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma

Anticancer Research

Volumn 23, Issue 2 C, 2003, Pages 1719-1722

  Murata, Kazumoto ^a   Shiraki, Katsuya ^a   Kawakita, Tomoyuki ^a   Yamamoto, Norihiko ^a   Okano, Hiroshi ^a   Nakamura, Masatsugu ^a   Sakai, Takahisa ^a   Deguchi, Masatoshi ^a   Ohmori, Shigeru ^a   Nakano, Takeshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced HCC; Arterial infusion chemotherapy; Low dose CDDP + 5 FU

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; TUMOR THROMBUS;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 12444335256     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Toyoda H, Nakano S, Takeda I, Sugimachi K, Osada T, Kiriyama S, Suga T and Takahashi M: The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology 52: 295-299, 1995.
2. Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I and Nakajo M: Transcatheter arterial chemoemolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 88: 1574-1581, 2000.
3. Urabe T, Kaneko S, Matsushita E, Unoura M and Kobayashi K: Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma. Oncology 55: 39-47, 1998.
4. Bhattacharya S, Novell JR, Dusheiko GM, Hilson AJ Dick R and Hobbs KE: Epirubicin-lipiodol chemotherapy versus 131 iodine-lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma. Cancer 76: 2202-2210, 1995.
5. Yoshikawa M, Sasho H, Ebara M, Iijima T, Iwama S, Endo F, Kimura M, Shimamura Y, Suzuki Y, Nakano T et al.: A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 33 Suppl: S149-152, 1994.
6. Ando E, Yamashita F, Tanaka M and Tanikawa K: A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 79: 1890-1896, 1997.
7. Okuda K, Tanaka M, Shibata J, Ando E, Ogata T, Kinoshita H, Eriguchi N, Aoyagi S and Tanikawa K: Hepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluorouracil for multiple recurrence of hepatocellular carcinoma after surgical treatment. Oncol Rep 6: 587-591, 1999.
8. Murata T, Nasu R, Kimura H, Uokawa K, Nagata K, Akagi K and Tanaka Y: Effect of hepatic function of hepatic artey infusion chemotherapy using epirubicin and mitoxantrone for advanced hepatocellular carcinoma. Gan To Kagaku Ryoho 25: 1707-1711, 1998.
9. Kamada K, Nakanishi T, Kitamoto M, Aikata H, Kawakami Y, Ito K, Asahara T and Kajiyama G: Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol 12: 847-854, 2001.
10. Ono Y, Yoshimasu T, Ashikaga R, Inoue M, Shindou H, Fiji K, Araki Y and Nishimura Y: Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol 23: 564-568, 2000.
11. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y and Ohnishi K: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 15: 918-928, 1985.